Abstract

Experience With IVDR Implementation in Three Diagnostic Laboratories: Messages to EU Health Institutions, Diagnostic Healthcare Payers, and Authorities.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force.
Isabel Dombrink ... Elisabeth Dequeker
HemaSphere | VOL. 6
Isabel Dombrink, et. al.Isabel Dombrink ... Elisabeth Dequeker
01 Jun 2022
Disharmonization in the Regulation of Transgenic Plants in Europe
Ramesh Bikram Karky ... Mark Perry
Biotechnology Law Report | VOL. 38
Ramesh Bikram Karky, et. al.Ramesh Bikram Karky ... Mark Perry
01 Dec 2019
Portuguese Food Composition Database Quality Management System
L M Oliveira ... I P Castanheira
European Journal of Clinical Nutrition | VOL. 64
L M Oliveira, et. al.L M Oliveira ... I P Castanheira
01 Nov 2010
Part II The New EU Prospectus Rules, 16 The Approval of Prospectus: Competent Authorities, Notifications, and Sanctions
Di Noia Carmine ... Gargantini Matteo
-
Di Noia Carmine, et. al.Di Noia Carmine ... Gargantini Matteo
20 Mar 2020
View more papers

More From: HemaSphere

Paper Title
Journal
Date
Author
Prospective genetic germline evaluation in a consecutive group of adult patients aged
Enrico Attardi ... Valeria Santini
HemaSphere | VOL. 8
Enrico Attardi, et. al.Enrico Attardi ... Valeria Santini
01 Jul 2024
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells.
Gloria Iacoboni ... Pere Barba
HemaSphere | VOL. 8
Gloria Iacoboni, et. al.Gloria Iacoboni ... Pere Barba
01 Jul 2024
Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience.
Judith M Boer ... C Michel Zwaan
HemaSphere | VOL. 8
Judith M Boer, et. al.Judith M Boer ... C Michel Zwaan
01 Jul 2024
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).
Frank G Rücker ...
HemaSphere | VOL. 8
Frank G Rücker, et. al.Frank G Rücker ...
01 Jul 2024
View more papers